J. Donald Capra, M.D., who led the Oklahoma Medical Research Foundation during a nine-year period of unprecedented growth, will retire as OMRF’s president, effective May 1, 2006. “When I came to OMRF in 1997, I still vividly recall that several members of our board took me aside and told me, each in their own way, […]
News
Mothers’ Clubs Bake for OMRF
A group of Edmond women tied on aprons, pulled out rolling pins and put their culinary skills to work by baking 50 apple pies and selling them to support medical research. The Edmond chapter of the Oklahoma Association of Mothers’ Clubs joined eight other chapters in raising $3,000 for the Oklahoma Medical Research Foundation. The […]
RF Hosting Women, Wealth and Wellness Conference
On May 6, the Oklahoma Medical Research Foundation will host the 2006 Women, Wealth and Wellness Conference. The event, which will provide women with strategies for improving their physical health and financial future, runs from 8 a.m. to 3:30 p.m. at OMRF, 825 NE 13. The conference will address such topics as balancing a family […]
Young scientists spend day researching in OMRF laboratories
Some of them needed stools to peer through the microscopes. Others had to double-roll the sleeves on their lab coats. But these minor inconveniences didn’t dampen the enthusiasm of the 17 Putnam City School District elementary students who spent Thursday morning in the labs of the Oklahoma Medical Research Foundation. “To think that I got […]
OMRF president testifies before Congress about medical research funding
Oklahoma Medical Research Foundation President J. Donald Capra, M.D., testified before the United States House of Representatives today. Speaking before the Subcommittee on Labor, Health and Human Services, Education and Related Agencies, Capra urged Congress to increase medical research funding. Specifically, he advocated for increases in the budgets of the National Institutes of Health and […]
Thalidomide offers promise against Lou Gehrig’s disease, OMRF researcher finds
A new study co-authored by an Oklahoma Medical Research Foundation scientist suggests that a once-controversial drug might extend the lives of patients with amyotrophic lateral sclerosis (ALS), the deadly neurological disease also known as Lou Gehrig’s disease. Kenneth Hensley, Ph.D., a scientist in OMRF’s Free Radical Biology and Aging Research Program, co-authored the study with […]
